David B. Weiner, Director at INOVIO PHARMACEUTICALS, INC. (INO), sold 9,000 shares at $1.95 ($18K) on 2022-05-16, disclosed to the SEC on 2022-05-17.
Scheduled sale ($18k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| INO | SELL | 2022-08-11 | $32K | — | Filing → |
| INO | SELL | 2022-03-14 | $13K | — | Filing → |
| INO | SELL | 2022-03-09 | $14K | — | Filing → |